Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction

Human Gene Therapy(2022)10.1089/hum.2022.162Source: DataRank Database

Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction is a research paper published in Human Gene Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.94)OA: greenTopics (57)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Kanut Laoharawee ORCID,Sajya M. Singh ORCID,Tam T. T. N. Nguyen ORCID,Miles C. Smith ORCID,Alexa Temme

Live enrichment

PubMed:36541357 PMC:PMC10024071 OpenAlex:https://openalex.org/W4312042812

NINDS NIH HHS

Grant: P30 NS062158

NIDDK NIH HHS

Grant: R41 DK094538

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10024071/pdf/hum.2022.162.pdf

publisherhttps://journals.sagepub.com/doi/full-xml/10.1089/hum.2022.162

publisherhttps://journals.sagepub.com/doi/pdf/10.1089/hum.2022.162

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10024071

Fields of Study

Lysosomal Storage Disorders ResearchVirus-based gene therapy researchNeurogenetic and Muscular Disorders ResearchHumansAnimalsMiceAgedQuality of LifeMucopolysaccharidosis IIMucopolysaccharidosis ICentral Nervous SystemIduronidaseIduronate SulfataseNervous System DiseasesCognitive DysfunctionGlycosaminoglycansDisease Models, Animal

MeSH Terms

AgedAnimalsCentral Nervous SystemDisease Models, AnimalGlycosaminoglycansHumansIduronate SulfataseIduronidaseMucopolysaccharidosis INervous System DiseasesQuality of LifeMucopolysaccharidosis IIMiceCognitive Dysfunction

Keywords

Enzyme replacement therapyLysosomal storage diseaseHunter syndromeMucopolysaccharidosis type IIMucopolysaccharidosis IGenetic enhancementMedicineCatabolismMucopolysaccharidosisNeurocognitiveMucopolysaccharidosis type IVector (molecular biology)DiseaseEnzymeStem cellInternal medicineBiologyGeneCognitionMetabolismBiochemistryGene therapyNeurodevelopmentAAVMps IiMps I

Sustainable Development Goals

SDG 0: Good health and well-being